Hydroxyprostaglandin Dehydrogenases
"Hydroxyprostaglandin Dehydrogenases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Catalyzes reversibly the oxidation of hydroxyl groups of prostaglandins.
| Descriptor ID |
D006911
|
| MeSH Number(s) |
D08.811.682.047.820.375
|
| Concept/Terms |
Hydroxyprostaglandin Dehydrogenases- Hydroxyprostaglandin Dehydrogenases
- Dehydrogenases, Hydroxyprostaglandin
- Hydroxyprostaglandin Dehydrogenase
- Dehydrogenase, Hydroxyprostaglandin
- Prostacyclin Dehydrogenase
- Dehydrogenase, Prostacyclin
|
Below are MeSH descriptors whose meaning is more general than "Hydroxyprostaglandin Dehydrogenases".
Below are MeSH descriptors whose meaning is more specific than "Hydroxyprostaglandin Dehydrogenases".
This graph shows the total number of publications written about "Hydroxyprostaglandin Dehydrogenases" by people in this website by year, and whether "Hydroxyprostaglandin Dehydrogenases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxyprostaglandin Dehydrogenases" by people in Profiles.
-
Pioglitazone, a PPAR? agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1. Cancer Prev Res (Phila). 2012 Oct; 5(10):1183-94.
-
Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes. Am J Physiol Gastrointest Liver Physiol. 2009 Sep; 297(3):G559-66.
-
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. Proc Natl Acad Sci U S A. 2009 Jun 09; 106(23):9409-13.
-
NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res (Phila). 2008 Sep; 1(4):241-9.
-
Structural and mutational analysis of Trypanosoma brucei prostaglandin H2 reductase provides insight into the catalytic mechanism of aldo-ketoreductases. J Biol Chem. 2005 Jul 15; 280(28):26371-82.
-
Preferential expression of hPGFS in primary SCCHN and tumour cell lines derived from respiratory and digestive organs. Br J Cancer. 2004 Mar 08; 90(5):1093-9.